LENZ - LENZ Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LENZ is currently covered by 5 analysts with an average price target of $27.6. This is a potential upside of $13.9 (432.82%) from yesterday's end of day stock price of $5.18.

LENZ Therapeutics's activity chart (see below) currently has 21 price targets and 27 ratings on display. The stock rating distribution of LENZ is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48.43% with an average time for these price targets to be met of 81.5 days.

Highest price target for LENZ is $50, Lowest price target is $12, average price target is $27.6.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 07-Jul-2026. First documented stock forecast 27-Mar-2024.

Currently out of the existing stock ratings of LENZ, 12 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Aug-2024

$38

$32.82 (633.59%)

$38

12 days ago
(07-Jul-2026)

6/11 (54.55%)

$32.1 (544.07%)

177

Buy Since 14-Apr-2025

$12

$6.18 (106.19%)

$67

2 months 7 days ago
(12-May-2026)

0/3 (0%)

$4.09 (51.71%)

Buy Since 14-Apr-2025

$12

$6.18 (106.19%)

$51

2 months 7 days ago
(12-May-2026)

0/2 (0%)

$4.09 (51.71%)

Buy Since 15-Aug-2024

$26

$20.18 (346.74%)

$45

3 months 23 days ago
(26-Mar-2026)

5/6 (83.33%)

$17.06 (190.83%)

146

Buy Since 31-Jul-2025

$50

$44.18 (759.11%)

$40

8 months 29 days ago
(20-Oct-2025)

1/2 (50%)

$13.69 (37.70%)

14

Show more analysts

Please expand the browser size to see the chart

What is LENZ (LENZ Therapeutics) average time for price targets to be met?

On average it took 81.5 days on average for the stock forecasts to be realized with a an average price target met ratio 48.43

Which analyst has the current highest performing score on LENZ (LENZ Therapeutics) with a proven track record?

YIGAL NOCHOMOVITZ

Which analyst has the most public recommendations on LENZ (LENZ Therapeutics)?

Yigal Nochomovitz works at CITI and has 29 price targets and 20 ratings on LENZ

Which analyst is the currently most bullish on LENZ (LENZ Therapeutics)?

Gary Nachman with highest potential upside - $44.82

Which analyst is the currently most reserved on LENZ (LENZ Therapeutics)?

Biren Amin with lowest potential downside - $6.18

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?